Share Name Share Symbol Market Type Share ISIN Share Description
Summit Corporation LSE:SUMM London Ordinary Share GB00BN40HZ01 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +24.00p +14.91% 185.00p 180.00p 190.00p 185.00p 165.00p 165.00p 2,272,496.00 15:56:15
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 1.4 -20.1 -28.8 - 113.75

Summit Corp Share Discussion Threads

Showing 38076 to 38100 of 38100 messages
Chat Pages: 1524  1523  1522  1521  1520  1519  1518  1517  1516  1515  1514  1513  Older
DateSubjectAuthorDiscuss
21/1/2017
15:38
Summit Therapeutics ‏@Summitplc Jan 19 More Join us 4 a webinar hosted by @ParentProjectMD 25 Jan @ 11am EST 2 discuss #utrophin, biomarker work & PhaseOut DMD http://community.parentprojectmd.org/events/upcoming-webinar-summit-s-utrophin-modulation-program …
football
21/1/2017
14:23
Per gmcc today from the other board: 'Hi Ivyspivey : Many thanks for sharing , all good exposure ! hTTp://cc.bingj.com/cache.aspx?q=panel+iii+%e2%80%93+anti+bacterial%2fmicrobiome+moderator%3a+sarah+haywood%2c+28th+jan+2017&d=5627567635754&mkt=en-GB&setlang=en-US&;w=QtENiXmeC83w1LQG9wWHMjeuVnO5V7Pj “The event, sponsored by J.P. Morgan, Numis, Penningtons Manches, PwC and Consilium Strategic Communications, and held in partnership with the MedCity, BioIndustry Association (BIA) and One Nucleus, will highlight the significant investment opportunities within the UK healthcare sector available to investors. This invitation-only, free to attend conference will showcase leading public and private UK life sciences companies through a series of short presentations and themed panel sessions. Jo Johnson MP, Minister of State for Universities, Science, Research and Innovation will deliver a keynote discussing Government strategies that will impact the Healthcare sector. Panels and Keynote presentations will tackle issues around most topical areas of healthcare technology and feature key representatives of Pfizer, Syncona, Immunocore, Oncimmune, Clinigen, BTG, Motif Bio, Kymab and many others" Good luck everyone'
chrisatrdg
21/1/2017
13:38
Reason for last weeks rise is I have upgraded my 2018 price tgt from 300 to 380p
patviera
21/1/2017
13:15
Wasn't aware of Mellon's issues elsewhere - FFWD or something else ? Could just be Griffiths still looking to liquidise all his Summit ? Edit. Over on nasdaq, possibly a move from SRPT into Smmt ?
luminoso
20/1/2017
19:26
At a guess I'd say it will likely be Griffiths or Mellon unloading the 2m shares to an II. Both have issues elsewhere. 2017 is going to be a year to remember in so many ways....
waterloo01
20/1/2017
19:22
Well that was a nice day was it not,just rewards for hanging on I say to the lth's Lets hope we don't get sellers from new positions sending us downwards yet again... good luck to all,have a nice weekend.. I also had GWMO dancing about all day only to be dragged down below a rise of, well a lot not sure 30% or more perhaps to Zero,or minus with more buys than sells,such a corrupt area this AIM exchange...bahhh
abergele
20/1/2017
17:47
Just dont declare it football ?
euroto
20/1/2017
17:29
So if this comes up Trumps no pun intended I've got to travel around the world for 5 years before I come back to my stately home to pay no tax. I got excited there when you said no tax after 5 years
football
20/1/2017
17:25
Good summary macmoss and very thankful for SIPP's and ISA's as can just ignore it (although this changes if you file outside UK, where they often don't recognise their tax free status).
waterloo01
20/1/2017
17:21
Rules on Capital gains has changed many times. At the moment residents in the UK pay Capital gains tax on profits made from selling shares no matter how long they have been held. Only non-residents pay no capital gains tax provided they don't return to the UK within 5 years of first leaving. The rate of Capital gains tax is dependent on ones tax band, so Capital gains tax rate will be charged at 10% or 20%, after deductions of any losses and taking account of the annual Capital gains tax allowance of £11,100.
macmoss
20/1/2017
17:21
The level of investment today in one day,I think,is unprecedented & which because the total shares in two tranches (assuming they are the same) exceeds 3% we will soon know who they are. It now looks to me that we are now getting the re-rating that this share deserves. Fingers crossed for next week.
chrisatrdg
20/1/2017
17:18
Cautiousmoney, if they were to change listing, it's more likely to be as a US company on Nasdaq, especially in todays environment, than a full listing on the LSE. If the £2m+ buys are an II, then assume they will be in for the ride!
waterloo01
20/1/2017
17:05
What a solid and encouraging day! I'm assuming this is not some significant piece of news about to break and more likely someone with significant funds waking up to the huge potential that will break here at some point in the near(no longer distant)future. Trump just bought the wife an inauguration present? Hope the rest of the day on the nasdaq continues in a continuing aforementioned pattern.
hugus maximus
20/1/2017
16:15
cautious money Are gains exempt after 5 years.I did not know that.
infocusint
20/1/2017
16:15
Any ideas as the source of the volume? Must be someone taking a position. New II about to reveal itself?
waterloo01
20/1/2017
15:12
Any thoughts on SUMM going for a full listing ?? to get clear of the casino that is AIM !
cautiousmoney
20/1/2017
15:10
Thanks FM1, it appears the move towards £32 may have begun ;-) as long as they wait until February for £30 plus, that's my first tranche bought here 5 years ago, so will be tax free :-))
cautiousmoney
20/1/2017
14:56
Yes mega buys
curlly
20/1/2017
14:55
Nobody noticed those two mega trades from around noon ?
theunluckyone
20/1/2017
13:16
up in the USA last nite and the price just catching up today here
football
20/1/2017
13:01
up 10% this am - whats occurring ? m
maurillac
19/1/2017
22:05
perhaps a nice end to the week for us,be a change,as still under water from my last top up..gla lth's
abergele
19/1/2017
21:28
NASDAQ close at 10.99 using $1.23 equates to £1.79 & which at current range on AIM of £1.55 to £1.67 makes it ahead of AIM so can we expect a breakout in UK to follow US. Would be good if share price in UK does follow US would be a good start to the climb back.
chrisatrdg
18/1/2017
17:13
CMO and COO Dr Ralf Rosskamp seems very involved with the PhaseOut trial so I wouldn't expect him to be going anywhere. I guess we might see and options RNS next to this new appointment. It would probably show some confidence it these new guys bought some stock too.... or if the current board toped up :-) They must be confident of a very healthy return but I guess it depends if they are sitting on news and allowed to buy right now. GLA
freemoney1
18/1/2017
16:17
Looks a positive appointment. Is this guy below as per RNS 2/9/15 still with us - just that the roles seem to overlap ? "Oxford, UK, 2 September 2015 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy ('DMD') and C. difficile infection ('CDI'), today announced the appointment of Dr Ralf Rosskamp as Chief Medical Officer" DJ
deejay007
Chat Pages: 1524  1523  1522  1521  1520  1519  1518  1517  1516  1515  1514  1513  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20170123 02:31:57